vitamin b12 supplement injection B-12 Injectable Solution Storage Store at controlled temperature between 2° and 30°C (36° and 86°F) Compounded Methylcobalamin (Vitamin B12) Injection,

Vestibular Cohorts : Small studies report 3050% reduction in Dizziness Handicap Inventory (DHI) scores after 3 months of B12 in patients with chronic dizziness and low-normal levels

While often temporary, this increase in platelets carries serious risks: Deep vein thrombosis (blood clots in deep veins, usually in legs) Pulmonary embolism (blood clots in lungs) Arterial thrombosis (clots in arteries) Cerebrovascular events (strokes) Coronary artery thrombosis (heart attacks) Splanchnic vein thrombosis (clots in abdominal veins) The risk is particularly high in: Elderly patients Those with pre-existing heart disease Patients with inherited blood-clotting disorders Immobilized individuals Those with hardened arteries Neurological Symptoms and Joint Pain Paradoxically, B12 replacement can temporarily worsen or trigger new neurological symptoms

Retrieved 2 April 2021

While both compounds are being researched for laboratory use, they work through completely different biochemical mechanisms that give valuable insights into metabolic processes

They can help you monitor your progress and make changes as needed